Insulin glargine and malignancy: an unwarranted alarm

Lancet. 2009 Aug 15;374(9689):511-3. doi: 10.1016/S0140-6736(09)61307-6. Epub 2009 Jul 17.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Dose-Response Relationship, Drug
  • Humans
  • Hypoglycemic Agents / adverse effects*
  • Incidence
  • Insulin / adverse effects
  • Insulin / analogs & derivatives*
  • Insulin Glargine
  • Insulin, Long-Acting
  • Neoplasms* / chemically induced
  • Neoplasms* / epidemiology
  • Proportional Hazards Models
  • Research Design*
  • Survival Analysis

Substances

  • Hypoglycemic Agents
  • Insulin
  • Insulin, Long-Acting
  • Insulin Glargine